DAMATO NICOLE sold $207K of INNV
DAMATO NICOLE (CHIEF LEGAL OFFICER) sold 23,814 shares of InnovAge Holding Corp. (INNV) at $8.70 ($0.21M total) on 2026-09-25 under a Rule 10b5-1 trading plan.
How this was made
The 30-second read
Why it matters
The disclosed sale is modest and likely to cause only short‑term price pressure.
Market read
A routine insider sale with limited material impact; traders may monitor for any follow‑on activity.
What to watch
The insider retains a large stake (304,897 shares) and the sale price matches recent market levels.
Background
Form 4 filings provide transparent disclosure of insider transactions, often used by traders to gauge sentiment.
Ticker impact
Chief Legal Officer sold 23,814 shares for $207,181, a 10b5-1 plan sale disclosed on Form 4.
likely modest pressure as the market prices in the insider sell.
Sale size is modest relative to holdings, but insider selling can prompt short-term downside bias.
Market effects
Minimal impact on the broader healthcare sector.
No significant regional effect.
Limited to investors tracking insider activity.
Counterpoint
The sale may be routine under a pre‑arranged plan and not indicative of company outlook.
Key entities
- CompanyInnovAge Holding Corp.
US‑listed biotech firm (NASDAQ: INNV).
- PersonNicole Damato
Chief Legal Officer of InnovAge.